Surface‐Based Morphometry Analysis of the Cerebral Cortex in Patients With Probable Idiopathic Rapid Eye Movement Sleep Behavior Disorder
Patients with piRBD displayed widespread atrophy in various brain regions, predominantly covering the motor and sensory cortex. Furthermore, LGI could serve as a prognostic biomarker of disease's progression in piRBD.
Authors
- Milad Najafzadeh (ORCID: https://orcid.org/0000-0003-1681-4837)
- Luigi Ferini‐Strambi (ORCID: https://orcid.org/0000-0003-2867-5424)
- Hossein Akbari‐Lalimi (ORCID: https://orcid.org/0000-0003-3753-8747)
- Zohre Ganji
- Hoda Zare
- Shahrokh Nasseri (ORCID: https://orcid.org/0000-0002-6973-8586)
- Athareh Saeeidian‐Mehr
Institutions
- Vita-Salute San Raffaele University (IT)
- Mashhad University of Medical Sciences (IR)
- Hormozgan University of Medical Sciences (IR)
Publication Details
- Journal
- Brain and Behavior
- Published
- 2024-09-30
- DOI
- https://doi.org/10.1002/brb3.70057
- Citations
- 1
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- Bristol-Myers Squibb
- Eli Lilly and Company
- Pfizer
- Sanofi
- Biogen
- Teva Pharmaceutical Industries
- Celgene
- Jazz Pharmaceuticals
- Neurocrine Biosciences
- Verily Life Sciences
- Voyager Therapeutics
- Mashhad University of Medical Sciences
- Servier
- H. Lundbeck A/S
- Sun Pharma
- Genentech
- Allergan
- Avid Radiopharmaceuticals